1. Home
  2. CASI vs RANI Comparison

CASI vs RANI Comparison

Compare CASI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • RANI
  • Stock Information
  • Founded
  • CASI 1991
  • RANI 2012
  • Country
  • CASI China
  • RANI United States
  • Employees
  • CASI N/A
  • RANI N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • CASI Health Care
  • RANI Health Care
  • Exchange
  • CASI Nasdaq
  • RANI Nasdaq
  • Market Cap
  • CASI 20.5M
  • RANI 23.2M
  • IPO Year
  • CASI 1996
  • RANI 2021
  • Fundamental
  • Price
  • CASI $1.29
  • RANI $0.53
  • Analyst Decision
  • CASI Strong Buy
  • RANI Strong Buy
  • Analyst Count
  • CASI 1
  • RANI 4
  • Target Price
  • CASI $4.00
  • RANI $7.75
  • AVG Volume (30 Days)
  • CASI 79.1K
  • RANI 4.7M
  • Earning Date
  • CASI 08-15-2025
  • RANI 08-12-2025
  • Dividend Yield
  • CASI N/A
  • RANI N/A
  • EPS Growth
  • CASI N/A
  • RANI N/A
  • EPS
  • CASI N/A
  • RANI N/A
  • Revenue
  • CASI $31,368,000.00
  • RANI $1,200,000.00
  • Revenue This Year
  • CASI N/A
  • RANI N/A
  • Revenue Next Year
  • CASI N/A
  • RANI N/A
  • P/E Ratio
  • CASI N/A
  • RANI N/A
  • Revenue Growth
  • CASI 8.39
  • RANI N/A
  • 52 Week Low
  • CASI $1.09
  • RANI $0.39
  • 52 Week High
  • CASI $7.67
  • RANI $3.75
  • Technical
  • Relative Strength Index (RSI)
  • CASI 42.66
  • RANI 49.58
  • Support Level
  • CASI $1.21
  • RANI $0.51
  • Resistance Level
  • CASI $1.77
  • RANI $0.59
  • Average True Range (ATR)
  • CASI 0.13
  • RANI 0.04
  • MACD
  • CASI 0.01
  • RANI 0.01
  • Stochastic Oscillator
  • CASI 14.29
  • RANI 70.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: